- All regions
- Asia
Hong Kong
India
Japan
Korea, Republic of
Singapore
Taiwan- Australasia
Australia
New Zealand- Europe
Austria
Belgium
Bosnia Herzegovina
Bulgaria
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Macedonia
Netherlands
Norway
Poland
Portugal
Romania
Serbia Montenegro
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
United Kingdom- North America
Canada
United States
Top stocks in United States
| Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
|---|---|---|---|
 BNCBNB Standard | $263.86m | 2.02 | n/a |
| ZUUSZeuus | $263.79m | n/a | n/a |
| SNFCASecurity National Financial | $263.58m | 6.69 | n/a |
| OACCOaktree Acquisition III Life Sciences | $263.53m | 39.02 | n/a |
| SMRTSmartRent | $262.51m | n/a | n/a |
| TGTredegar | $262.43m | 7.82 | n/a |
| LCAAUL Catterton Asia Acquisition | $262.25m | 251.49 | n/a |
| ATIIUArchimedes Tech SPAC Partners II | $262.17m | n/a | n/a |
| FACTUFACT II Acquisition | $261.94m | 68.54 | n/a |
| FACTFACT II Acquisition | $261.94m | 68.35 | n/a |
| SVIASilvia | $261.94m | n/a | n/a |
| NTWONewbury Street II Acquisition | $261.66m | 52.89 | n/a |
| ACUAcme United | $261.12m | 28.69 | 0.94% |
| NKSHNational Bankshares | $260.88m | 16.25 | 3.74% |
| BDSXBiodesix | $260.82m | n/a | n/a |
| ABEOAbeona Therapeutics | $260.76m | n/a | n/a |
| LCTXLineage Cell Therapeutics | $260.49m | n/a | n/a |
| ULBIUltralife | $260.30m | 55.51 | n/a |
| HVIIUHennessy Capital Investment VII | $260.23m | 119.62 | n/a |
| IMRXImmuneering | $260.08m | n/a | n/a |